Not for use with other long-acting β 2-agonists. Do not exceed recommended dose. Prescribe a short-acting, inhaled β 2-agonist for acute symptoms; monitor for increased need. Monitor for signs ...
Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... in a single inhaler, the Ellipta. Sales of the drug are starting to pick up since its ...
Breo Ellipta, a dual-therapy inhaler combining an ICS and LABA, was similarly found to provide comparable or incremental net health benefits when compared to generic ICS/LABA inhalers. ICER's ...
Hosted on MSN4mon
Are dry powder inhalers the key to sustainable respiratory care?Efforts to supplant pressurised metered-dose inhalers (pMDIs ... followed by Relvar/Breo Ellipta and Seretide/Advair GlobalData is the parent company of Medical Device Network.
Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US ... in a single inhaler, the Ellipta. Sales of the drug are starting to pick up since its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results